MicroRNA‐140‐5p targeting tumor necrosis factor‐α prevents pulmonary arterial hypertension
Authors:
- 26 October 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 234 (6) , 9535-9550
Abstract
Background: Pulmonary arterial hypertension (PAH) is characterized by the apoptosis resistance and hyperproliferation of pulmonary artery smooth muscle cells (PASMCs). Its pathogenesis has not been revealed. Here, we carried out experiments to investigate the functions of miR‐140‐5p and tumor necrosis factor‐α (TNF‐α).Methods: We selected GSE703 from Gene Expression Omnibus (GEO) Database to conduct microarray analysis using R software and Gene Set Enrichment Analysis (GSEA). Combing bioinformatics results, the upregulation of miR‐140‐5p inhibited PAH progression through targeting TNF‐α. RNA expression was measured by quantitative real‐time polymerase chain reaction (RT‐qPCR) and protein level was measured by western blot analysis and enzyme‐linked immunosorbent assays (ELISA). We conducted monocrotaline (MCT) injection to rats to form PAH animal models. The lung tissues were observed by hematoxylin–eosin (HE) staining and Sirius red‐picric acid staining. Right ventricular systolic pressure (RVSP) and the ratio of right ventricle (RV)‐to‐left ventricle (LV) plus septum (S) weight (RV/[LV + S]) were measured in MCT‐induced animal models. Overexpression of miR‐140‐5p and TNF‐α were utilized to research the proliferation, migration, and phenotypic variation of hypoxia‐mediated PASMCs. The binding between miR‐140‐5p and TNF‐α 3′‐untranslated region (3′‐UTR) was confirmed via luciferase reporter assay.Results: Downregulation of miR‐140‐5p and upregulation of TNF‐α were observed in PAH rat model and hypoxia‐mediated PASMCs. And we proved that overexpression of miR‐140‐5p could suppress the proliferation, migration, and phenotypic variation of PASMCs, therefore inhibiting PAH pathogenesis. Luciferase assay verified that miR‐140‐5p targeted TNF‐α directly. A converse correlation was also shown between miR‐140‐5p and TNF‐α in PASMCs.Conclusions: miR‐140‐5p and TNF‐α are important regulators in PAH pathology and may serve as a therapeutic target for PAH.Keywords
Funding Information
- Natural Science Foundation of Henan Province (162300410216, 182300410332)
- National Natural Science Foundation of China (81673423, 81570723, 81800051, U1704168)
This publication has 42 references indexed in Scilit:
- Updated Clinical Classification of Pulmonary HypertensionJACC, 2013
- Reduced MicroRNA-150 Is Associated with Poor Survival in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Claudin-1 expression in airway smooth muscle exacerbates airway remodeling in asthmatic subjectsJournal of Allergy and Clinical Immunology, 2011
- Rab1 GTPase regulates phenotypic modulation of pulmonary artery smooth muscle cells by mediating the transport of angiotensin II type 1 receptor under hypoxiaThe International Journal of Biochemistry & Cell Biology, 2011
- Dynamic Changes in Lung MicroRNA Profiles During the Development of Pulmonary Hypertension due to Chronic Hypoxia and MonocrotalineArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary HypertensionCirculation, 2009
- Role of TNF-α-induced reactive oxygen species in endothelial dysfunction during reperfusion injuryAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Increased plasma monocyte chemoattractant protein‐1 level in idiopathic pulmonary arterial hypertensionRespirology, 2006
- Pathologic assessment of vasculopathies in pulmonary hypertensionJACC, 2004
- Interleukin-1 Receptor Antagonist Treatment Reduces Pulmonary Hypertension Generated in Rats by MonocrotalineAmerican Journal of Respiratory Cell and Molecular Biology, 1994